Indonesia DIA-RAMADAN Study: A Real-life, Prospective and Observational of Gliclazide MR in Type-2 Diabetes Patients During Ramadan Fasting
Background: Sulfonylureas (SUs) have been widely used in many countries for T2DM treatment. Gliclazide is one of the SUs with the lowest risk of hypoglycemia; however, the safety and effectiveness of gliclazide MR during Ramadan has not yet been reported in Indonesia. This study aimed to assess safe...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2022-01-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | https://www.actamedindones.org/index.php/ijim/article/view/1758 |